BS
Betz Stephen F. Directeur Scientifique
Other M
US US · SEC (Form 4)
Explore the full record of transactions filed by Betz Stephen F., Directeur Scientifique. Director active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. In total, 29 disclosures have been published. Total volume traded: €3.2m. The latest transaction was disclosed on 2 May 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations 29 total
€62,091 3,247 shares @ €19.1226 0.0014% mcap 2.0% of flow
Common Stock
SEC:0001209191-22-027145:0 · 2 May 2022
€135,588 5,664 shares @ €23.9385 0.0030% mcap 4.3% of flow
Common Stock
SEC:0001209191-22-025190:0 · 18 Apr 2022
€196,578 9,000 shares @ €21.842 0.0044% mcap 6.2% of flow
Common Stock
SEC:0001209191-22-023556:0 · 4 Apr 2022
€79,206 4,164 shares @ €19.0216 0.0018% mcap 2.5% of flow
Common Stock
SEC:0001209191-22-022036:0 · 31 Mar 2022
€54,052 3,123 shares @ €17.3076 0.0012% mcap 1.7% of flow
Common Stock
SEC:0001209191-22-019595:0 · 15 Mar 2022
016,500 shares 0
Common Stock
SEC:0001209191-22-015130:0 · 28 Feb 2022
€51,487 3,123 shares @ €16.4863 0.0012% mcap 1.6% of flow
Common stock
SEC:0001209191-22-010784:0 · 15 Feb 2022
€52,256 3,123 shares @ €16.7325 0.0012% mcap 4.1% of flow
Common stock
SEC:0001209191-22-006797 · 1 Feb 2022
€52,256 3,123 shares @ €16.7325 0.0012% mcap 1.7% of flow
Common stock
SEC:0001209191-22-006797:0 · 1 Feb 2022
€85,073 4,168 shares @ €20.4109 0.0019% mcap 2.7% of flow
Common stock
SEC:0001209191-22-004051:0 · 18 Jan 2022
€85,073 4,168 shares @ €20.4109 0.0019% mcap 6.6% of flow
Common stock
SEC:0001209191-22-004051 · 18 Jan 2022
€176,593 7,168 shares @ €24.6363 0.0040% mcap 13.7% of flow
Common stock
SEC:0001209191-22-002197 · 3 Jan 2022
€176,593 7,168 shares @ €24.6363 0.0040% mcap 5.6% of flow
Common stock
SEC:0001209191-22-002197:0 · 3 Jan 2022
€74,008 3,000 shares @ €24.6695 0.0017% mcap 5.8% of flow
Common stock
SEC:0001209191-21-071646 · 28 Dec 2021
€74,008 3,000 shares @ €24.6695 0.0017% mcap 2.3% of flow
Common stock
SEC:0001209191-21-071646:0 · 28 Dec 2021
€121,501 5,668 shares @ €21.4363 0.0027% mcap 9.4% of flow
Common stock
SEC:0001209191-21-070272 · 15 Dec 2021
€121,501 5,668 shares @ €21.4363 0.0027% mcap 3.9% of flow
Common stock
SEC:0001209191-21-070272:0 · 15 Dec 2021
€136,969 5,668 shares @ €24.1653 0.0031% mcap 10.6% of flow
Common stock
SEC:0001209191-21-067840 · 1 Dec 2021
€136,969 5,668 shares @ €24.1653 0.0031% mcap 4.3% of flow
Common stock
SEC:0001209191-21-067840:0 · 1 Dec 2021
€132,515 5,668 shares @ €23.3795 0.0030% mcap 10.3% of flow
Common stock
SEC:0001209191-21-065149 · 15 Nov 2021
€132,515 5,668 shares @ €23.3795 0.0030% mcap 4.2% of flow
Common stock
SEC:0001209191-21-065149:0 · 15 Nov 2021
€304,790 12,600 shares @ €24.1897 0.0069% mcap 23.7% of flow
Common stock
SEC:0001209191-21-063679 · 5 Nov 2021
€304,790 12,600 shares @ €24.1897 0.0069% mcap 9.7% of flow
Common stock
SEC:0001209191-21-063679:0 · 5 Nov 2021
€121,583 5,668 shares @ €21.4508 0.0027% mcap 9.5% of flow
Common stock
SEC:0001209191-21-062731 · 1 Nov 2021
€121,583 5,668 shares @ €21.4508 0.0027% mcap 3.9% of flow
Common stock
SEC:0001209191-21-062731:0 · 1 Nov 2021
25 of 29 declarations
Load more (4 remaining) About Betz Stephen F. Stephen F. Betz is an executive at Crinetics Pharmaceuticals, Inc.